Melanoma Stocks List

Recent Signals

Date Stock Signal Type
2021-04-16 AGEN Hammer Candlestick Bullish
2021-04-16 AGEN Stochastic Reached Oversold Weakness
2021-04-16 AIM Narrow Range Bar Range Contraction
2021-04-16 AIM Spinning Top Other
2021-04-16 ARWR Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-16 ARWR Bollinger Band Squeeze Range Contraction
2021-04-16 BMY Stochastic Reached Overbought Strength
2021-04-16 BMY Pocket Pivot Bullish Swing Setup
2021-04-16 BMY Upper Bollinger Band Walk Strength
2021-04-16 CLBS Lizard Bullish Bullish Day Trade Setup
2021-04-16 CLBS Doji - Bullish? Reversal
2021-04-16 CLBS Stochastic Buy Signal Bullish
2021-04-16 CSTL Fell Below 20 DMA Bearish
2021-04-16 DCTH Narrow Range Bar Range Contraction
2021-04-16 DCTH NR7 Range Contraction
2021-04-16 DMTK NR7 Range Contraction
2021-04-16 DMTK Stochastic Buy Signal Bullish
2021-04-16 GALT Calm After Storm Range Contraction
2021-04-16 GALT 20 DMA Resistance Bearish
2021-04-16 GALT MACD Bearish Signal Line Cross Bearish
2021-04-16 IOVA Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-16 IOVA 20 DMA Resistance Bearish
2021-04-16 IOVA New Uptrend Bullish
2021-04-16 IOVA Bollinger Band Squeeze Range Contraction
2021-04-16 ISR Fell Below 200 DMA Bearish
2021-04-16 KNTE Bearish Engulfing Bearish
2021-04-16 KNTE Fell Below 20 DMA Bearish
2021-04-16 MYGN 180 Bearish Setup Bearish Swing Setup
2021-04-16 SRTS 200 DMA Support Bullish
2021-04-16 SSKN 20 DMA Support Bullish
2021-04-16 SSKN Bollinger Band Squeeze Range Contraction
2021-04-16 TIL New 52 Week Low Weakness
2021-04-16 TIL Hammer Candlestick Bullish
2021-04-16 TIL Hot IPO Pullback Bullish Swing Setup
2021-04-16 VCNX Doji - Bullish? Reversal

Recent News for Melanoma Stocks

Date Stock Title
Apr 18 BMY AACR 2021 highlights Eli Lilly’s new KRAS battle; Affimed’s Natural Killer cell therapy
Apr 17 ACHL The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
Apr 16 GALT Galectin Therapeutics: The Galectin Signature - Signed, Sealed, And About To Be Delivered
Apr 16 BMY U.S. Food and Drug Administration Approves Opdivo® (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma....
Apr 16 BMY FDA approves Bristol's Opdivo as first-line gastric cancer treatment
Apr 16 BMY Latest Upgrades and Downgrades: Bristol-Myers Squibb, Splunk, Tesla
Apr 16 BMY Bristol-Myers Gastric-Cancer Treatment Cleared by FDA
Apr 16 IOVA IOVA, LSCC, WIT and GSX among premarket gainers
Apr 16 ARWR Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results
Apr 16 CSTL Castle Biosciences Presents Data at the 10th World Congress of Melanoma and 17th European Association of Dermato-Oncology Congress
Apr 16 BMY The Smartest Stocks to Buy With $200 Right Now
Apr 15 DMTK OptumInsight Study Describes Cost Savings of DermTech’s Pigmented Lesion Assay in the Management of Melanoma
Apr 15 GALT Company News for Apr 15, 2021
Apr 15 BMY Bristol Myers' (BMY) Opdivo Combo Gets EU Nod for First-Line RCC
Apr 15 ONCS OncoSec to Present Encore Interim Data from the KEYNOTE-695 Phase 2b Clinical Trial at the 10th World Congress of Melanoma
Apr 15 BMY The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
Apr 15 ARWR Arrowhead Announces ARO-DUX4 as First Muscle Targeted RNAi Candidate Using TRiMTM Platform
Apr 15 NAVB Navidea Biopharmaceuticals Announces Acceptance of Therapeutics Focused Abstract for Presentation at the Frontiers in Cancer Immunotherapy Symposium
Apr 15 CSTL Late-Breaking New Independent Validation Study of 1,674 Patients Demonstrates Castle Biosciences' i31-GEP Artificial Intelligence Algorithm Improves Precision of Sentinel Lymph Node Positivity Prediction in Cutaneous Melanoma
Apr 15 ARWR Arrowhead Pharmaceuticals: RNAi And The Knockdown Effect

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Sometimes they develop from a mole with changes such as an increase in size, irregular edges, change in color, itchiness, or skin breakdown.The primary cause of melanoma is ultraviolet light (UV) exposure in those with low levels of skin pigment. The UV light may be from either the sun or from other sources, such as tanning devices. About 25% develop from moles. Those with many moles, a history of affected family members, and who have poor immune function are at greater risk. A number of rare genetic defects such as xeroderma pigmentosum also increase risk. Diagnosis is by biopsy and analysis of any skin lesion that has signs of being potentially cancerous.Using sunscreen and avoiding UV light may prevent melanoma. Treatment is typically removal by surgery. In those with slightly larger cancers, nearby lymph nodes may be tested for spread. Most people are cured if spread has not occurred. For those in whom melanoma has spread, immunotherapy, biologic therapy, radiation therapy, or chemotherapy may improve survival. With treatment the five-year survival rates in the United States is 98% among those with localized disease and 17% among those in whom spread has occurred. The likelihood that it will come back or spread depends how thick the melanoma is, how fast the cells are dividing, and whether or not the overlying skin has broken down.Melanoma is the most dangerous type of skin cancer. Globally, in 2012, it newly occurred in 232,000 people. In 2015 there were 3.1 million with active disease which resulted in 59,800 deaths. Australia and New Zealand have the highest rates of melanoma in the world. There are also high rates in Northern Europe and North America, while it is less common in Asia, Africa, and Latin America. Melanoma is more common in men than women. Melanoma has become more common since the 1960s in areas which are mostly populated with white people.

More about Melanoma
Browse All Tags